Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly clinical trials

To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP

This study is testing a new drug called batoclimab for adults with a nerve condition called Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). It aims to see how well it works and if it's safe compared to a dummy drug.